Find a Research Lab

Enter a research interest, principal investigator or keyword

Displaying 91 to 100 of 122 results for cancer

Show: 10 · 20 · 50

  1. 8
  2. 9
  3. 10
  4. 11
  5. 12
  • Richard John Jones Lab

    The Richard J. Jones Lab studies normal and cancerous stem cells in order to make clinical improvements in areas such as blood and marrow transplantation (BMT). We discovered one of the most common stem-cell markers, Aldefluor, which identifies cells based on their expression of aldehyde dehydrogenase 1 (ALDH1), and have used this marker to detect and characterize normal stem cells and cancer stem cells from many hematologic malignancies. We also developed post-transplant cyclophosphamide and effective related haploidentical BMT.

    Research Areas: enzymes, stem cells, blood and marrow transplantation, leukemia, cancer

    Principal Investigator

    Richard Jones, M.D.

    Department

    Medicine

  • Richard Rivers Lab

    The Richard Rivers Lab researches vascular communication with a focus on microcirculation physiology. Our team seeks to determine how metabolic demands are passed between tissue and the vascular network as well as along the vascular network itself. Our goal is to better understand processes of diseases such as cancer and diabetes, which could lead to the development of more targeted drugs and treatment. We are also working to determine the role for inwardly rectifying potassium channels (Kir) 2.1 and 6.1 in signaling along the vessel wall as well as the role of gap junctions.

    Research Areas: cancer, potassium, diabetes, vascular biology, vascular, microcirculation

  • Richard W. TeLinde Endowed Gynecologic Pathology Lab

    Our scientists pursue out-of-the-box approaches at the very edge of knowledge to:
    1) Elucidate the molecular/cellular/physiological landscapes of ovarian and uterine cancers.
    2) Understand the earliest events in their development and mechanisms of tumor evolution/dormancy and drug resistance.
    3) Deliver promises for better prevention, detection and treatment to women who have diseases or are at an increased risk to have these cancers.

    Research Areas: uterine cancer, gestational trophoblastic disease, ovarian cancer

  • Robert Anders Lab

    Dr. Anders’ laboratory focuses on the basic processes that lead to cancer. His team approaches these questions through the use of both experimental models and examination of human tissues. His team is specifically interested in interrogating the immune microenvironment of cancer, detecting circulating cancer cells and preventing cancer metastasis.

    Research Areas: cancer, translational research, immunotherapy, liver cancer

    Lab Website

    Principal Investigator

    Robert Anders, M.D., Ph.D.

    Department

    Oncology
    Pathology

  • Saleh Alqahtani Lab

    The Saleh Alqahtani Lab has conducted clinical research on the management of fatty liver disease and viral hepatitis, including novel therapies. We’ve also been involved in various clinical trials related to liver cirrhosis, liver cancer and outcomes of liver transplant patients.

    Research Areas: fatty liver disease, Hepatitis, liver transplants, cirrhosis, liver diseases, liver cancer

    Principal Investigator

    Saleh Alqahtani, M.B.Ch.B., M.S.

    Department

    Medicine

  • Samuel R. Denmeade Laboratory

    The main research goals of my laboratory are: (1) to identify and study the biology of novel cancer selective targets whose enzymatic function can be exploited for therapeutic and diagnostic purposes; (2) to develop methods to target novel agents for activiation by these cancer selective targets while avoiding or minimizing systemic toxicity; (3) to develop novel agents for imaging cancer sites at earliest stages. To accomplish these objectives the lab has originally focused on the development of prodrugs or protoxins that are inactive when given systemically via the blood and only become activated by tumor or tissue specific proteases present within sites of tumor. Using this approach, we are developing therapies targeted for activation by the serine proteases prostate-specific antigen (PSA), human glandular kallikrein 2 (hK2) and fibroblast activation protein (FAP) as well as the membrane carboxypeptidase prostate-specific membrane antigen (PSMA). One such approach developed in the l...ab consists of a potent bacterial protoxin that we have reengineered to be selectively activated by PSA within the Prostate. This PSA-activated toxin is currently being tested clinically as treatment for men with recurrent prostate cancer following radiation therapy. In a related approach, a novel peptide-cytotoxin prodrug candidate that is activated by PSMA has been identified and is this prodrug candidate is now entering early phase clinical development. In addition, we have also identified a series of potent inhibitors of PSA that are now under study as drug targeting and imaging agents to be used in the treatment and detection of prostate cancer.
    view less

    Research Areas: cancer therapies, prodrugs, cancer, protease inhibitors, protoxins, cancer imaging

  • Saowanee Ngamruengphong Lab

    Research in the Saowanee Ngamruengphong Lab focuses on methods for diagnosing and managing gastrointestinal conditions, including premalignant and malignant lesions of the gastrointestinal tract, esophageal cancer, colon polyps, and biliary and pancreatic disease. Our most recent work includes investigating a novel hybrid technique for closure of refractory gastrocutaneous fistula. We also conducted an international multicenter study that compared endoscopic ultrasound-guided pancreatic duct drainage with enteroscopy-assisted endoscopic retrograde pancreatography following Whipple surgery.

    Research Areas: colon polyps, cancer, endoscopy, pancreatic disease, gastric cancer, ultrasound, gastrointestinal

    Principal Investigator

    Saowanee Ngamruengphong, M.D.

    Department

    Medicine

  • Saraswati Sukumar Lab

    Our lab is focused on using comprehensive gene expression, methylation and sequencing and metabolomics analysis to identify alterations in breast cancer, and exploiting these for early detection and therapy. Among deferentially expressed genes, our lab has focused on the HOX genes. HOX genes are intimately involved in the development of resistance to both chemotherapy and to agents targeting the estrogen receptor. Our work explores the alternate pathways that are activated by HOX proteins leading to this resistance and novel treatments to overcome resistance in both tissue culture and xenograft models. In addition, epigenetically silenced genes and a metabolic reprogramming in tumors also trigger novel early detection and therapeutic strategies. We are testing the utility of differentiation therapy through reactivating RAR-beta in breast cancer using histone deacetylase inhibitors with great success. Also, we are targeting enzymes involved in gluconeogenesis and glycolysis with small ...molecule FDA-approved antimetabolites to achieve antitumor effects. view more

    Research Areas: breast cancer, genetics

    Lab Website

    Principal Investigator

    Saraswati Sukumar, Ph.D.

    Department

    Oncology

  • Sean Taverna Laboratory

    The Taverna Laboratory studies histone marks, such as lysine methylation and acetylation, and how they contribute to an epigenetic/histone code that dictates chromatin-templated functions like transcriptional activation and gene silencing. Our lab uses biochemistry and cell biology in a variety of model organisms to explore connections between gene regulation and proteins that write and read histone marks, many of which have clear links to human diseases like leukemia and other cancers. We also investigate links between small RNAs and histone marks involved in gene silencing.

    Research Areas: biochemistry, histone marks, cell biology, leukemia, cancer, epigenetics, eukaryotic cells, gene silencing, RNA

  • Shawn Lupold Laboratory

    The Shawn Lupold Laboratory studies the biology of urologic malignancies, like prostate cancer, to create new experimental diagnostic, prognostic and therapeutic agents.

    Research Areas: prostate cancer, urologic cancers

    Lab Website

    Principal Investigator

    Shawn Lupold, Ph.D.

    Department

    Urology

  1. 8
  2. 9
  3. 10
  4. 11
  5. 12